ID: ALA472926

Max Phase: Preclinical

Molecular Formula: C23H21N5O2

Molecular Weight: 399.45

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(C(=O)Nc2ccc(C)c(Nc3nc(-c4cccnc4)c[nH]3)c2)cc1

Standard InChI:  InChI=1S/C23H21N5O2/c1-15-5-8-18(26-22(29)16-6-9-19(30-2)10-7-16)12-20(15)27-23-25-14-21(28-23)17-4-3-11-24-13-17/h3-14H,1-2H3,(H,26,29)(H2,25,27,28)

Standard InChI Key:  LQKJZECPLMTFEG-UHFFFAOYSA-N

Associated Targets(Human)

Tyrosine-protein kinase receptor FLT3 13481 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Platelet-derived growth factor receptor 285 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 399.45Molecular Weight (Monoisotopic): 399.1695AlogP: 4.78#Rotatable Bonds: 6
Polar Surface Area: 91.93Molecular Species: NEUTRALHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.14CX Basic pKa: 7.53CX LogP: 4.24CX LogD: 3.89
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.43Np Likeness Score: -1.53

References

1. Mahboobi S, Sellmer A, Eswayah A, Elz S, Uecker A, Böhmer FD..  (2008)  Inhibition of PDGFR tyrosine kinase activity by a series of novel N-(3-(4-(pyridin-3-yl)-1H-imidazol-2-ylamino)phenyl)amides: a SAR study on the bioisosterism of pyrimidine and imidazole.,  43  (7): [PMID:17983688] [10.1016/j.ejmech.2007.09.021]

Source